NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 04:00PM ET
6.32
Dollar change
+0.53
Percentage change
9.15
%
Index- P/E- EPS (ttm)-0.58 Insider Own2.64% Shs Outstand16.08M Perf Week22.72%
Market Cap101.62M Forward P/E- EPS next Y- Insider Trans0.71% Shs Float15.65M Perf Month38.60%
Income-6.25M PEG- EPS next Q- Inst Own5.66% Short Float2.53% Perf Quarter19.25%
Sales12.53M P/S8.11 EPS this Y- Inst Trans30.99% Short Ratio2.21 Perf Half Y156.91%
Book/sh0.20 P/B32.26 EPS next Y- ROA-12.38% Short Interest0.40M Perf Year39.98%
Cash/sh0.45 P/C14.15 EPS next 5Y- ROE-34.75% 52W Range1.29 - 7.75 Perf YTD35.91%
Dividend Est.- P/FCF57.09 EPS past 5Y39.27% ROI-17.14% 52W High-18.45% Beta2.07
Dividend TTM- Quick Ratio0.85 Sales past 5Y-17.07% Gross Margin14.32% 52W Low389.92% ATR (14)0.59
Dividend Ex-DateApr 01, 2022 Current Ratio0.85 EPS Y/Y TTM87.49% Oper. Margin-60.34% RSI (14)69.27 Volatility11.87% 13.98%
Employees10 Debt/Eq0.53 Sales Y/Y TTM-36.30% Profit Margin-49.83% Recom- Target Price-
Option/ShortYes / Yes LT Debt/Eq0.47 EPS Q/Q91.26% Payout- Rel Volume1.24 Prev Close5.79
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume179.54K Price6.32
SMA2037.12% SMA5024.09% SMA20078.77% Trades Volume222,279 Change9.15%
Apr-10-25 08:00AM
Mar-31-25 10:30AM
Mar-28-25 04:10PM
Mar-26-25 09:00AM
Feb-26-25 02:00PM
08:30AM Loading…
Feb-20-25 08:30AM
Feb-18-25 08:30AM
Feb-13-25 03:00PM
Feb-03-25 07:30AM
Jan-31-25 03:51PM
Jan-15-25 07:00AM
Jan-10-25 08:30AM
Jan-09-25 11:30AM
Dec-18-24 04:00PM
Nov-27-24 07:00AM
05:23PM Loading…
Nov-12-24 05:23PM
Nov-06-24 08:30AM
Oct-30-24 10:30AM
Oct-23-24 05:00PM
Oct-09-24 08:30AM
Oct-02-24 08:30AM
Sep-10-24 11:00AM
Sep-09-24 08:00AM
Aug-26-24 08:45AM
Aug-23-24 11:00AM
Aug-19-24 06:30PM
Aug-13-24 08:30AM
Jul-25-24 08:30AM
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Virland AChief Financial OfficerDec 06 '24Buy3.003,0009,0003,000Dec 10 02:54 PM
Tassiopoulos PeterChief Executive OfficerSep 09 '24Buy2.065,00010,278420,000Sep 11 11:57 AM